 | • レポートコード：GIR-107A14634 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、細胞株開発血清のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細胞株開発血清の種類別市場規模（ウシ胎児血清、成人ウシ血清、その他）、用途別市場規模（組織エンジニアリング＆再生医療、毒性試験、研究、創薬、バイオプロダクション）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・細胞株開発血清の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：American Type Culture Collection (ATCC) (US)、Lonza Group AG (Switzerland)、Thermo Fisher Scientific, Inc. (US)、GE Healthcare (U.K.)、Sigma-Aldrich Corporation (US)、Selexis SA (Switzerland)、European Collection of Cell Cultures (ECACC) (U.K.)、Corning, Inc. (US)、WuXi AppTec, Inc. (China)、Sartorious AG (Germany) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ウシ胎児血清、成人ウシ血清、その他 ・用途別分析2016年-2026年：組織エンジニアリング＆再生医療、毒性試験、研究、創薬、バイオプロダクション ・細胞株開発血清の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・細胞株開発血清のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・細胞株開発血清のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・細胞株開発血清の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・細胞株開発血清の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cell Line Development Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cell Line Development Serum size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cell Line Development Serum market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cell Line Development Serum market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fetal Bovine Serum
Adult Bovine Serum
Others
Market segment by Application can be divided into
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
Bioproduction
The key market players for global Cell Line Development Serum market are listed below:
American Type Culture Collection (ATCC) (US)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (US)
GE Healthcare (U.K.)
Sigma-Aldrich Corporation (US)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (US)
WuXi AppTec, Inc. (China)
Sartorious AG (Germany)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cell Line Development Serum product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cell Line Development Serum, with price, sales, revenue and global market share of Cell Line Development Serum from 2019 to 2021.
Chapter 3, the Cell Line Development Serum competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Line Development Serum breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cell Line Development Serum market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cell Line Development Serum sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cell Line Development Serum Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cell Line Development Serum Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Fetal Bovine Serum
1.2.3 Adult Bovine Serum
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cell Line Development Serum Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Tissue Engineering & Regenerative Medicines
1.3.3 Toxicity Testing
1.3.4 Research
1.3.5 Drug Discovery
1.3.6 Bioproduction
1.4 Global Cell Line Development Serum Market Size & Forecast
1.4.1 Global Cell Line Development Serum Sales in Value (2016-2026))
1.4.2 Global Cell Line Development Serum Sales in Volume (2016-2026)
1.4.3 Global Cell Line Development Serum Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Cell Line Development Serum Production Capacity Analysis
1.5.1 Global Cell Line Development Serum Total Production Capacity (2016-2026)
1.5.2 Global Cell Line Development Serum Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cell Line Development Serum Market Drivers
1.6.2 Cell Line Development Serum Market Restraints
1.6.3 Cell Line Development Serum Trends Analysis
2 Manufacturers Profiles
2.1 American Type Culture Collection (ATCC) (US)
2.1.1 American Type Culture Collection (ATCC) (US) Details
2.1.2 American Type Culture Collection (ATCC) (US) Major Business
2.1.3 American Type Culture Collection (ATCC) (US) Cell Line Development Serum Product and Services
2.1.4 American Type Culture Collection (ATCC) (US) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Lonza Group AG (Switzerland)
2.2.1 Lonza Group AG (Switzerland) Details
2.2.2 Lonza Group AG (Switzerland) Major Business
2.2.3 Lonza Group AG (Switzerland) Cell Line Development Serum Product and Services
2.2.4 Lonza Group AG (Switzerland) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Thermo Fisher Scientific, Inc. (US)
2.3.1 Thermo Fisher Scientific, Inc. (US) Details
2.3.2 Thermo Fisher Scientific, Inc. (US) Major Business
2.3.3 Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Product and Services
2.3.4 Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 GE Healthcare (U.K.)
2.4.1 GE Healthcare (U.K.) Details
2.4.2 GE Healthcare (U.K.) Major Business
2.4.3 GE Healthcare (U.K.) Cell Line Development Serum Product and Services
2.4.4 GE Healthcare (U.K.) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sigma-Aldrich Corporation (US)
2.5.1 Sigma-Aldrich Corporation (US) Details
2.5.2 Sigma-Aldrich Corporation (US) Major Business
2.5.3 Sigma-Aldrich Corporation (US) Cell Line Development Serum Product and Services
2.5.4 Sigma-Aldrich Corporation (US) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Selexis SA (Switzerland)
2.6.1 Selexis SA (Switzerland) Details
2.6.2 Selexis SA (Switzerland) Major Business
2.6.3 Selexis SA (Switzerland) Cell Line Development Serum Product and Services
2.6.4 Selexis SA (Switzerland) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 European Collection of Cell Cultures (ECACC) (U.K.)
2.7.1 European Collection of Cell Cultures (ECACC) (U.K.) Details
2.7.2 European Collection of Cell Cultures (ECACC) (U.K.) Major Business
2.7.3 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Product and Services
2.7.4 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Corning, Inc. (US)
2.8.1 Corning, Inc. (US) Details
2.8.2 Corning, Inc. (US) Major Business
2.8.3 Corning, Inc. (US) Cell Line Development Serum Product and Services
2.8.4 Corning, Inc. (US) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 WuXi AppTec, Inc. (China)
2.9.1 WuXi AppTec, Inc. (China) Details
2.9.2 WuXi AppTec, Inc. (China) Major Business
2.9.3 WuXi AppTec, Inc. (China) Cell Line Development Serum Product and Services
2.9.4 WuXi AppTec, Inc. (China) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Sartorious AG (Germany)
2.10.1 Sartorious AG (Germany) Details
2.10.2 Sartorious AG (Germany) Major Business
2.10.3 Sartorious AG (Germany) Cell Line Development Serum Product and Services
2.10.4 Sartorious AG (Germany) Cell Line Development Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cell Line Development Serum Sales by Manufacturer
3.1 Global Cell Line Development Serum Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cell Line Development Serum Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cell Line Development Serum
3.4 Market Concentration Rate
3.4.1 Top 3 Cell Line Development Serum Manufacturer Market Share
3.4.2 Top 6 Cell Line Development Serum Manufacturer Market Share
3.5 Global Cell Line Development Serum Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cell Line Development Serum Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cell Line Development Serum Market Size by Region
4.1.1 Global Cell Line Development Serum Sales in Volume by Region (2016-2026)
4.1.2 Global Cell Line Development Serum Revenue by Region (2016-2026)
4.2 North America Cell Line Development Serum Revenue (2016-2026)
4.3 Europe Cell Line Development Serum Revenue (2016-2026)
4.4 Asia-Pacific Cell Line Development Serum Revenue (2016-2026)
4.5 South America Cell Line Development Serum Revenue (2016-2026)
4.6 Middle East and Africa Cell Line Development Serum Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cell Line Development Serum Sales in Volume by Type (2016-2026)
5.2 Global Cell Line Development Serum Revenue by Type (2016-2026)
5.3 Global Cell Line Development Serum Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cell Line Development Serum Sales in Volume by Application (2016-2026)
6.2 Global Cell Line Development Serum Revenue by Application (2016-2026)
6.3 Global Cell Line Development Serum Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cell Line Development Serum Sales by Type (2016-2026)
7.2 North America Cell Line Development Serum Sales by Application (2016-2026)
7.3 North America Cell Line Development Serum Market Size by Country
7.3.1 North America Cell Line Development Serum Sales in Volume by Country (2016-2026)
7.3.2 North America Cell Line Development Serum Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cell Line Development Serum Sales by Type (2016-2026)
8.2 Europe Cell Line Development Serum Sales by Application (2016-2026)
8.3 Europe Cell Line Development Serum Market Size by Country
8.3.1 Europe Cell Line Development Serum Sales in Volume by Country (2016-2026)
8.3.2 Europe Cell Line Development Serum Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cell Line Development Serum Sales by Type (2016-2026)
9.2 Asia-Pacific Cell Line Development Serum Sales by Application (2016-2026)
9.3 Asia-Pacific Cell Line Development Serum Market Size by Region
9.3.1 Asia-Pacific Cell Line Development Serum Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cell Line Development Serum Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cell Line Development Serum Sales by Type (2016-2026)
10.2 South America Cell Line Development Serum Sales by Application (2016-2026)
10.3 South America Cell Line Development Serum Market Size by Country
10.3.1 South America Cell Line Development Serum Sales in Volume by Country (2016-2026)
10.3.2 South America Cell Line Development Serum Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cell Line Development Serum Sales by Type (2016-2026)
11.2 Middle East & Africa Cell Line Development Serum Sales by Application (2016-2026)
11.3 Middle East & Africa Cell Line Development Serum Market Size by Country
11.3.1 Middle East & Africa Cell Line Development Serum Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cell Line Development Serum Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cell Line Development Serum Typical Distributors
12.3 Cell Line Development Serum Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cell Line Development Serum Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cell Line Development Serum Revenue by Application, (USD Million), 2021-2026
Table 3. American Type Culture Collection (ATCC) (US) Basic Information, Manufacturing Base and Competitors
Table 4. American Type Culture Collection (ATCC) (US) Major Business
Table 5. American Type Culture Collection (ATCC) (US) Cell Line Development Serum Product and Services
Table 6. American Type Culture Collection (ATCC) (US) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Lonza Group AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 8. Lonza Group AG (Switzerland) Major Business
Table 9. Lonza Group AG (Switzerland) Cell Line Development Serum Product and Services
Table 10. Lonza Group AG (Switzerland) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Thermo Fisher Scientific, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 12. Thermo Fisher Scientific, Inc. (US) Major Business
Table 13. Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Product and Services
Table 14. Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GE Healthcare (U.K.) Basic Information, Manufacturing Base and Competitors
Table 16. GE Healthcare (U.K.) Major Business
Table 17. GE Healthcare (U.K.) Cell Line Development Serum Product and Services
Table 18. GE Healthcare (U.K.) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sigma-Aldrich Corporation (US) Basic Information, Manufacturing Base and Competitors
Table 20. Sigma-Aldrich Corporation (US) Major Business
Table 21. Sigma-Aldrich Corporation (US) Cell Line Development Serum Product and Services
Table 22. Sigma-Aldrich Corporation (US) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Selexis SA (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 24. Selexis SA (Switzerland) Major Business
Table 25. Selexis SA (Switzerland) Cell Line Development Serum Product and Services
Table 26. Selexis SA (Switzerland) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. European Collection of Cell Cultures (ECACC) (U.K.) Basic Information, Manufacturing Base and Competitors
Table 28. European Collection of Cell Cultures (ECACC) (U.K.) Major Business
Table 29. European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Product and Services
Table 30. European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Corning, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 32. Corning, Inc. (US) Major Business
Table 33. Corning, Inc. (US) Cell Line Development Serum Product and Services
Table 34. Corning, Inc. (US) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. WuXi AppTec, Inc. (China) Basic Information, Manufacturing Base and Competitors
Table 36. WuXi AppTec, Inc. (China) Major Business
Table 37. WuXi AppTec, Inc. (China) Cell Line Development Serum Product and Services
Table 38. WuXi AppTec, Inc. (China) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sartorious AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 40. Sartorious AG (Germany) Major Business
Table 41. Sartorious AG (Germany) Cell Line Development Serum Product and Services
Table 42. Sartorious AG (Germany) Cell Line Development Serum Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Cell Line Development Serum Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 44. Global Cell Line Development Serum Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Cell Line Development Serum, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Cell Line Development Serum Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 47. Head Office and Cell Line Development Serum Production Site of Key Manufacturer
Table 48. Cell Line Development Serum New Entrant and Capacity Expansion Plans
Table 49. Cell Line Development Serum Mergers & Acquisitions in the Past Five Years
Table 50. Global Cell Line Development Serum Sales by Region (2016-2021e) & (K Pcs)
Table 51. Global Cell Line Development Serum Sales by Region (2021-2026) & (K Pcs)
Table 52. Global Cell Line Development Serum Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Cell Line Development Serum Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Cell Line Development Serum Sales by Type (2016-2021e) & (K Pcs)
Table 55. Global Cell Line Development Serum Sales by Type (2021-2026) & (K Pcs)
Table 56. Global Cell Line Development Serum Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Cell Line Development Serum Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Cell Line Development Serum Price by Type (2016-2021e) & (USD/Pcs)
Table 59. Global Cell Line Development Serum Price by Type (2021-2026) & (USD/Pcs)
Table 60. Global Cell Line Development Serum Sales by Application (2016-2021e) & (K Pcs)
Table 61. Global Cell Line Development Serum Sales by Application (2021-2026) & (K Pcs)
Table 62. Global Cell Line Development Serum Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Cell Line Development Serum Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Cell Line Development Serum Price by Application (2016-2021e) & (USD/Pcs)
Table 65. Global Cell Line Development Serum Price by Application (2021-2026) & (USD/Pcs)
Table 66. North America Cell Line Development Serum Sales by Country (2016-2021e) & (K Pcs)
Table 67. North America Cell Line Development Serum Sales by Country (2021-2026) & (K Pcs)
Table 68. North America Cell Line Development Serum Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Cell Line Development Serum Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Cell Line Development Serum Sales by Type (2016-2021e) & (K Pcs)
Table 71. North America Cell Line Development Serum Sales by Type (2021-2026) & (K Pcs)
Table 72. North America Cell Line Development Serum Sales by Application (2016-2021e) & (K Pcs)
Table 73. North America Cell Line Development Serum Sales by Application (2021-2026) & (K Pcs)
Table 74. Europe Cell Line Development Serum Sales by Country (2016-2021e) & (K Pcs)
Table 75. Europe Cell Line Development Serum Sales by Country (2021-2026) & (K Pcs)
Table 76. Europe Cell Line Development Serum Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Cell Line Development Serum Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Cell Line Development Serum Sales by Type (2016-2021e) & (K Pcs)
Table 79. Europe Cell Line Development Serum Sales by Type (2021-2026) & (K Pcs)
Table 80. Europe Cell Line Development Serum Sales by Application (2016-2021e) & (K Pcs)
Table 81. Europe Cell Line Development Serum Sales by Application (2021-2026) & (K Pcs)
Table 82. Asia-Pacific Cell Line Development Serum Sales by Region (2016-2021e) & (K Pcs)
Table 83. Asia-Pacific Cell Line Development Serum Sales by Region (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Cell Line Development Serum Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Cell Line Development Serum Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Cell Line Development Serum Sales by Type (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Cell Line Development Serum Sales by Type (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Cell Line Development Serum Sales by Application (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Cell Line Development Serum Sales by Application (2021-2026) & (K Pcs)
Table 90. South America Cell Line Development Serum Sales by Country (2016-2021e) & (K Pcs)
Table 91. South America Cell Line Development Serum Sales by Country (2021-2026) & (K Pcs)
Table 92. South America Cell Line Development Serum Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Cell Line Development Serum Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Cell Line Development Serum Sales by Type (2016-2021e) & (K Pcs)
Table 95. South America Cell Line Development Serum Sales by Type (2021-2026) & (K Pcs)
Table 96. South America Cell Line Development Serum Sales by Application (2016-2021e) & (K Pcs)
Table 97. South America Cell Line Development Serum Sales by Application (2021-2026) & (K Pcs)
Table 98. Middle East & Africa Cell Line Development Serum Sales by Country (2016-2021e) & (K Pcs)
Table 99. Middle East & Africa Cell Line Development Serum Sales by Country (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Cell Line Development Serum Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Cell Line Development Serum Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Cell Line Development Serum Sales by Type (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Cell Line Development Serum Sales by Type (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Cell Line Development Serum Sales by Application (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Cell Line Development Serum Sales by Application (2021-2026) & (K Pcs)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Cell Line Development Serum Typical Distributors
Table 109. Cell Line Development Serum Typical Customers
List of Figures
Figure 1. Cell Line Development Serum Picture
Figure 2. Global Cell Line Development Serum Sales Market Share by Type in 2020
Figure 3. Fetal Bovine Serum
Figure 4. Adult Bovine Serum
Figure 5. Others
Figure 6. Global Cell Line Development Serum Sales Market Share by Application in 2020
Figure 7. Tissue Engineering & Regenerative Medicines
Figure 8. Toxicity Testing
Figure 9. Research
Figure 10. Drug Discovery
Figure 11. Bioproduction
Figure 12. Global Cell Line Development Serum Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Cell Line Development Serum Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Cell Line Development Serum Sales (2016-2026) & (K Pcs)
Figure 15. Global Cell Line Development Serum Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Cell Line Development Serum Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Cell Line Development Serum Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Cell Line Development Serum Market Drivers
Figure 19. Cell Line Development Serum Market Restraints
Figure 20. Cell Line Development Serum Market Trends
Figure 21. Global Cell Line Development Serum Sales Market Share by Manufacturer in 2020
Figure 22. Global Cell Line Development Serum Revenue Market Share by Manufacturer in 2020
Figure 23. Cell Line Development Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Cell Line Development Serum Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Cell Line Development Serum Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Cell Line Development Serum Sales Market Share by Region (2016-2026)
Figure 27. Global Cell Line Development Serum Revenue Market Share by Region (2016-2026)
Figure 28. North America Cell Line Development Serum Revenue (2016-2026) & (USD Million)
Figure 29. Europe Cell Line Development Serum Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Cell Line Development Serum Revenue (2016-2026) & (USD Million)
Figure 31. South America Cell Line Development Serum Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Cell Line Development Serum Revenue (2016-2026) & (USD Million)
Figure 33. Global Cell Line Development Serum Sales Market Share by Type (2016-2026)
Figure 34. Global Cell Line Development Serum Revenue Market Share by Type (2016-2026)
Figure 35. Global Cell Line Development Serum Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Cell Line Development Serum Sales Market Share by Application (2016-2026)
Figure 37. Global Cell Line Development Serum Revenue Market Share by Application (2016-2026)
Figure 38. Global Cell Line Development Serum Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Cell Line Development Serum Sales Market Share by Type (2016-2026)
Figure 40. North America Cell Line Development Serum Sales Market Share by Application (2016-2026)
Figure 41. North America Cell Line Development Serum Sales Market Share by Country (2016-2026)
Figure 42. North America Cell Line Development Serum Revenue Market Share by Country (2016-2026)
Figure 43. United States Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Cell Line Development Serum Sales Market Share by Type (2016-2026)
Figure 47. Europe Cell Line Development Serum Sales Market Share by Application (2016-2026)
Figure 48. Europe Cell Line Development Serum Sales Market Share by Country (2016-2026)
Figure 49. Europe Cell Line Development Serum Revenue Market Share by Country (2016-2026)
Figure 50. Germany Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Cell Line Development Serum Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Cell Line Development Serum Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Cell Line Development Serum Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Cell Line Development Serum Revenue Market Share by Region (2016-2026)
Figure 59. China Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Cell Line Development Serum Sales Market Share by Type (2016-2026)
Figure 66. South America Cell Line Development Serum Sales Market Share by Application (2016-2026)
Figure 67. South America Cell Line Development Serum Sales Market Share by Country (2016-2026)
Figure 68. South America Cell Line Development Serum Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Cell Line Development Serum Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Cell Line Development Serum Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Cell Line Development Serum Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Cell Line Development Serum Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Cell Line Development Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界のフォーミュラフィードウシ血清市場 2021：企業別、地域別、種類・用途別 The Formula Fed Bovine Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界の新生ウシ血清市場 2021：企業別、地域別、種類・用途別 The Newborn Bovine Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の胎児ウシ血清（FBS）市場予測（～2024年）：メーカー別、地域別、種類・用途別 Fetal bovine serum (FBS) is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells. Scope of the Report: The worldwide market for Fetal Bovine Serum (FBS) is expected to grow at a CAGR of roughly xx% over the next five …
- 世界の胎児ウシ血清（FBS）市場予測（～2024年）：メーカー別、地域別、種類・用途別 Fetal bovine serum (FBS) is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells. Scope of the Report: The worldwide market for Fetal Bovine Serum (FBS) is expected to grow at a CAGR of roughly xx% over the next five …
- 世界の成牛血清市場予測（～2024年）：メーカー別、地域別、種類・用途別 Adult Bovine Serum, greater than 12 months, is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells. Scope of the Report: The worldwide market for Adult Bovine Serum is expected to grow at a CAGR of roughly xx% over t…